Diagnostic Accuracy of NICE Classification to Predict Deep Submucosal Invasion
Launched by ASOCIACIÓN ESPAÑOLA DE GASTROENTEROLOGÍA · Dec 26, 2014
Trial Information
Current as of June 09, 2025
Completed
Keywords
ClinConnect Summary
In the first phase of the study, a learning program of NICE classification based on examples will be performed. Forty images will be evaluated before and after the learning program.
In the second phase of the study, all consecutive patients who underwent to a colonoscopy will be included if a lesion greater than 1 cm is found and the endoscopy is performed with a high definition colonoscope with Narrow Band Imaging (NBI). Patients, lesions and endoscopy equipment characteristics will be recorded.
Subsequently, histological diagnosis of the lesion will also be recorded. Evaluated test (NIC...
Gender
ALL
Eligibility criteria
- Inclusion patients criteria:
- • Patients\> 18 years
- • Lesion Type 0 of Paris classification, greater than 1 cm, found in a colonoscopy performed by any medical indication with a high definition endoscope with Narrow Band Imaging.
- • Achievable histology by endoscopic or surgical resection.
- • Writing informed consent given.
- Exclusion patients criteria:
- • Age \<18 years.
- • Refusal to give informed consent.
- • Contraindication for endoscopic or surgical resection.
- • Urgent colonoscopy indication (eg severe rectorrhagia.).
- • Patients with inflammatory bowel disease.
- • Suspected metastatic neoplasia by previous imaging tests.
- Exclusion lesions criteria:
- • Polyp previously biopsied or resected.
- • Poor preparation that does not allow a proper assessment of the lesion.
- • NBI not performed.
- • Unavailable or indefinite histology (endoscopic or surgical resection).
About Asociación Española De Gastroenterología
The Asociación Española de Gastroenterología (AEG) is a leading professional organization dedicated to advancing the field of gastroenterology in Spain. Committed to promoting research, education, and clinical practice in digestive health, AEG plays a vital role in fostering collaboration among healthcare professionals, researchers, and institutions. Through its support of clinical trials and innovative studies, AEG aims to enhance patient care, develop new therapeutic strategies, and improve outcomes for individuals with gastrointestinal disorders. With a focus on scientific rigor and ethical standards, AEG is at the forefront of driving advancements in gastroenterological research and practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Manresa, Barcelona, Spain
Patients applied
Trial Officials
Pablo Vega
Principal Investigator
Complexo Hospitalario de Ourense
Maria Luisa de Castro
Principal Investigator
Complexo Hospitalario Universitario de Vigo-CHUVI
Eva Martínez-Bauer
Principal Investigator
Corporacion Parc Tauli
Angel Fernández
Principal Investigator
Hospital Clínico de Zaragoza
Gema de la Poza
Principal Investigator
Hospital de Fuenlabrada
Jorge López
Principal Investigator
Hospital de Móstoles
Oscar Nogales
Principal Investigator
Gregorio Marañón Hospital
Beatriz Peñas
Principal Investigator
Hospital Universitario Ramon y Cajal
Pilar Díez
Principal Investigator
Hospital Río Ortega
Marta Hernández
Principal Investigator
Hospital Universitario Puerta de Hierro
Antonio Zebenzuy
Principal Investigator
Hospital Universitario de Canarias
Aurora Burgos
Principal Investigator
Hospital Universitario La Paz
Jorge Mendoza
Principal Investigator
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Marco Antonio Álvarez
Principal Investigator
Hospital del Mar
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials